BD Awarded Vizient Innovative Technology Pact for CentroVena One System

Becton, Dickinson and Company, commonly known as BD (BDX), recently announced that its CentroVena One Insertion System has been recognized with an Innovative Technology contract by Vizient, the largest healthcare performance improvement organization in the United States. This designation, according to Yahoo Finance, underscores the system's potential to significantly improve the efficiency and safety of peripheral intravenous (PIV) vascular access procedures. The CentroVena One Insertion System is designed to streamline the process of initiating PIV lines, which are among the most frequently performed invasive medical procedures globally. The innovative aspects of the system aim to reduce the complexities associated with venous access, potentially leading to better patient outcomes and increased operational effectiveness for healthcare providers. Vizient's rigorous evaluation process for Innovative Technology contracts involves a thorough review by clinicians from its member institutions. These experts assess new products and technologies for their ability to deliver clinical improvements, patient safety enhancements, and overall value within the healthcare landscape. The contract award suggests that the CentroVena One system met these stringent criteria. For healthcare organizations, securing such a contract can facilitate the adoption of new technologies more readily. Vizient’s membership includes a vast network of hospitals and healthcare providers, making these contracts influential in product procurement decisions. The agreement with BD signifies Vizient’s recommendation of the CentroVena One system as a valuable addition to their members' clinical tools. The widespread use of PIVs means that any advancement in their insertion methodology can have a broad impact. Challenges such as difficult venous access can lead to multiple attempts, patient discomfort, and increased resource utilization. The CentroVena One Insertion System seeks to mitigate these issues through its innovative design and functionality, potentially offering a more consistent and successful first-attempt insertion rate. This contract positions BD to expand the reach of its CentroVena One system across numerous healthcare facilities associated with Vizient. It represents a significant endorsement from the healthcare community, validating the technology's role in advancing patient care and operational efficiency in vascular access.